Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M93,781Revenue $M9,703Net Margin (%)32.4Altman Z-Score18.4
Enterprise Value $M92,216EPS $12.4Operating Margin %43.5Piotroski F-Score9
P/E(ttm)28.6Beneish M-Score-2.3Pre-tax Margin (%)43.3Higher ROA y-yY
Price/Book8.010-y EBITDA Growth Rate %26.5Quick Ratio2.3Cash flow > EarningsY
Price/Sales9.45-y EBITDA Growth Rate %25.5Current Ratio2.7Lower Leverage y-yY
Price/Free Cash Flow28.9y-y EBITDA Growth Rate %54.9ROA % (ttm)24.0Higher Current Ratio y-yY
Dividend Yield %--PEG1.1ROE % (ttm)31.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M235ROIC % (ttm)36.0Gross Margin Increase y-yY

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBVanguard Health Care Fund 2015-03-31 Buy 0.31%$334.65 - $475.98
($394.14)
$ 398.681%New holding339,100
BIIBJoel Greenblatt 2015-03-31 Sold Out -0.014%$334.65 - $475.98
($394.14)
$ 398.681%Sold Out0
BIIBMario Gabelli 2015-03-31 Reduce$334.65 - $475.98
($394.14)
$ 398.681%Reduce 0.06%4,932
BIIBKen Fisher 2015-03-31 Add$334.65 - $475.98
($394.14)
$ 398.681%Add 2.28%81,058
BIIBKen Heebner 2014-12-31 Sold Out -0.75%$299.1 - $360.67
($323.29)
$ 398.6823%Sold Out0
BIIBVanguard Health Care Fund 2014-12-31 Sold Out -0.2%$299.1 - $360.67
($323.29)
$ 398.6823%Sold Out0
BIIBJoel Greenblatt 2014-12-31 Reduce-0.08%$299.1 - $360.67
($323.24)
$ 398.6823%Reduce 84.03%5,012
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 398.6821%New holding80,000
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 398.6821%Reduce 58.26%233,600
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 398.6821%New holding31,391
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 398.6833%Sold Out0
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 398.6833%Add 386.61%88,885
BIIBVanguard Health Care Fund 2014-06-30 Reduce-0.03%$274 - $320.13
($301.05)
$ 398.6832%Reduce 6.62%559,700
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 398.6833%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 398.6833%Sold Out0
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 398.6833%Add 41.76%8,632
BIIBMario Gabelli 2014-06-30 Add$274 - $320.13
($301.05)
$ 398.6832%Add 16.46%4,175
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 398.6826%New holding116,000
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 398.6826%Reduce 32.19%599,400
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 398.6826%New holding7,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCANGOS GEORGE ACEO 2015-05-01Sell1,362$377.526.26view
SCANGOS GEORGE ACEO 2015-04-01Sell1,362$423.2-5.21view
Sandrock AlfredGrp SVP, Chief Medical Officer 2015-03-27Sell430$430.12-6.74view
Cox JohnEVP Pharmaceutical Oper & Tech 2015-03-25Sell12,010$449.06-10.67view
Rowinsky Eric KDirector 2015-03-20Sell11,667$475-15.55view
Rowinsky Eric KDirector 2015-03-19Sell2,333$436.14-8.02view
Rowinsky Eric KDirector 2015-03-17Sell4,667$425.45-5.71view
DiPietro KennethEVP Human Resources 2015-03-16Sell803$415.46-3.44view
SCANGOS GEORGE ACEO 2015-03-13Sell537$412.69-2.8view
SHERWIN STEPHEN ADirector 2015-03-10Sell6,000$409.67-2.08view

Press Releases about BIIB :

    Quarterly/Annual Reports about BIIB:

    News about BIIB:

    Articles On GuruFocus.com
    8 Top Healthcare Stocks to Watch May 13 2015 
    Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
    Vanguard Healthcare Fund Adds Four New Positions May 01 2015 
    Biogen or Bluebird: Which Will Lead in SCD? Apr 30 2015 
    Analysts Provide Update for Biogen, PTC Therapeutics, GW Pharma, and Isis Pharma Apr 22 2015 
    Biogen And Idec To Part Ways After Inventing Alzheimer's Drug Mar 27 2015 
    Biogen’s Alzheimer’s Drug Shows Promising Test Results Mar 23 2015 
    Biogen Idec (BIIB) At All-time High Levels, KB Home (KBH) Revenue Growth Trajectory, Ctrip (CTRP) Re Mar 23 2015 
    The Best Upcoming Dividend Stocks Mar 20 2015 
    This Week’s Pharma Highlights Mar 19 2015 

    More From Other Websites
    BlueBird Bio: Another Biogen Rout In The Making? May 21 2015
    Jim Cramer Answers Your Twitter Questions on Tesla, Jarden, Williams-Sonoma, Wayfair May 21 2015
    Biogen to Present at Bernstein’s 31st Annual Strategic Decisions Conference May 20 2015
    3 Things Biogen's Management Wants You to Know May 19 2015
    Value plays in health care, financials & tech May 19 2015
    Good year for stock pickers: Pro May 19 2015
    Billionaire Stanley Druckenmiller’s Top Value Picks Include Illumina, Inc. (ILMN), Biogen Inc... May 19 2015
    3 Best Biotech Stocks to Add to Your Portfolio May 19 2015
    Is the Stock Market Due for a Correction? May 18 2015
    The Morning Download: Hardware Advances Bring Deep Learning, Real-Time Analytics Closer to... May 15 2015
    Fidelity Adds to Biogen, Amazon and Sells Microsoft, Amex May 14 2015
    Buy Microsoft, Biogen for Performance, Avoid Consumer Discretionary Stocks May 14 2015
    Biogen Promotes Former Dell Exec as CIO to 'Drive Innovation' May 14 2015
    Biogen to Present at the 2015 UBS Global Healthcare Conference May 13 2015
    3 Biotech Stocks See Growing Short Interest May 13 2015
    Biogen Names Matt Griffiths as Chief Information Officer May 13 2015
    Biogen Names Matt Griffiths as Chief Information Officer May 13 2015
    Short Sellers Start to Get Nervous on Biotech May 12 2015
    Is This Biogen's Next Billion-Dollar Blockbuster? May 11 2015
    Biogen Announces Massive $5 Billion Stock Repurchase Program: Share Value To Go Up May 08 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK